Protein Expression Er (Estrogen Receptor) in Breast Cancer Degree of Malignancy Mild, Moderate, and Severe
Downloads
Introduction: Mammary carcinoma is the most common malignancy and main mortality cause in women. Hormonal status (ER and PR expression) was long used as patient suitability for hormonal therapy. However, lately there have been many patients with ER and PR negative. This study wanted to prove the relevance of protein expression of ER (estrogen receptor) with the histopathological degree of malignancy of breast invasive ductal cancer and the prognosis of breast cancer with ER protein expression of positive and negative.
Methods: In this retrospective and cross sectional analytical study retrieved data about hormonal status (ER expression) and histopathological grading of inï¬ltrating ductal carcinoma patients. This study consisted of 201 patients with mammary carcinoma who referred to medical records Department Pathology Anatomic of Faculty Medicine Airlangga University/Dr. Soetomo General Hospital Surabaya on 1 January 2010–31 December 2010 and their medical record suitable with inclusion criterias. The data was categorized into several groups based on the ER expression result.
Results: Most of the sample was in 41–50 year age group (37.31%), and 54,7% of them were in poor expression. The relationship of estrogen receptor (ER) with the degree of histopathology inï¬ltrating ductal carcinoma patients, obtained p-value = 0.001 (p < 0.5) and the 2 í— 2 table is only moderate and severe degrees compared with the results of ER expression results obtained p = 0.001 (p < 0.5) and odds ratio of 0.362 (CI: 0194-0675).
Conclusion: This study found signiï¬cant correlation between ER expression with histopathological grading of inï¬ltrating ductal carcinoma patients.
Babiker, F.A., et al., 2002. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc. Res, 53(3), 709–19.
Couse, J.F., et al., 1997. Tissue distribution and quantitative analysis of estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology, 138(11), 4613–21.
Hess, R.A., 2003. Estrogen in the adult male reproductive tract: A review. Reproductive Biology and Endocrinology, 1(52), 52.
Lee, A., et al., 2007. Expression of c-erbB2, cyclin Dl and Estrogen Receptor and their Clinical Implications in the Invasive Ductal Carcinoma of the Breast. Japan Journal of Clinical Oncology, 37(9), 708–714.
Lester, S.C., 2010. The Breast in Robbins and Cotrans Pathology Basic of Disease, 8 ed. Pensylvania: Elsevier Saunders.
Authors who publish with Jurnal Ners agree to the following terms:
- Authors transfer the Copyright and grant Jurnal Ners the right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Jurnal Ners.
- Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Ners.
Jurnal Ners requires a formal written declaration and transfer of copyright from the author(s) for each article published. We, therefore, ask you to complete and return this form, retaining a copy for your own records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication. The form can be downloaded HERE.
